We hypothesized that the resistant SK-N-AS neuroblastoma cells had undergone an epigenetic reprogramming to alter their MES cell state and thus enhancing the transcription of RBM39. To test this hypothesis, we derived cell lines from three independent SK-N-AS indisulam-resistant tumors. This evidence concerns the gene RBM39 and neuroblastoma.